Skip to main content

A869 20 mg Pill - gray & white capsule/oblong, 16mm

Pill with imprint A869 20 mg is Gray & White, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 20 mg. It is supplied by Actavis Pharma, Inc.

Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for A869 20 mg

Methylphenidate hydrochloride extended-release 20 mg A869 20 mg

Methylphenidate Hydrochloride Extended-Release

A869 20 mg
20 mg
Gray & White
16.00 mm
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.